The latest market price of brivaracetam/brivaracetam in 2025

Since its launch, Brivaracetam/Brivaracetam has been widely used to treat focal epileptic seizures due to its unique neurological mechanism of action and good tolerability, especially for patients who have poor response to traditional anti-epileptic drugs. As a highly selective SV2A ligand, it is considered an optimized and upgraded version of levetiracetam. While reducing abnormal nerve discharges, it also causes fewer side effects such as anxiety, insomnia, and emotional instability. It has gradually occupied a more important position in international treatment guidelines.

In terms of application, Brivaracetam is suitable for patients over 16 years old. It can be used alone or in combination with other anti-epileptic drugs to treat focal seizures. It has a rapid onset of action and is convenient to administer. It can maintain a stable blood concentration after being taken twice a day, making it suitable for long-term management of chronic epilepsy. For many patients who do not benefit from first-line treatment, brivaracetam provides a new option that is relatively mild and has proven efficacy. Although it is mainly used for focal seizures, it has also shown good control of secondary generalized seizures in some cases, making it an important treatment option for refractory epilepsy.

Regarding market price and accessibility, the original drug of Brivaracetam has not yet been officially launched in mainland China, so domestic patients cannot obtain it through conventional channels. According to data from overseas channels, the original European version of Briviracetam (such as the brand name Briviact produced by UCB Company) has a specification of 50mg*60 tablets and its overseas selling price is approximately RMB 4,000. However, this price may fluctuate due to exchange rate changes, logistics costs and intermediate links. At present, there is no generic version of the drug in the Chinese market, which means that if patients need the drug, they can only choose to obtain it through channels such as overseas or overseas direct mail, which greatly limits its popularity and accessibility.

Reference materials:https://www.briviact.com/